ArticleCureus2025
Outcomes of Cesarean Myomectomies Performed at a Tertiary Care Hospital in North India: A Series of 10 Cases.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Uterine fibroids are common benign tumors in reproductive-aged women, and their prevalence in pregnancy is increasing. While cesarean myomectomy (CM) has traditionally been discouraged due to concerns about intraoperative hemorrhage and maternal morbidity, emerging evidence suggests it can be safely performed in selected cases. This retrospective case series evaluates the clinical outcomes of CM performed at a tertiary care center in North India over two years. Methods A total of 10 pregnant women who underwent CM were included in this study. Data were collected retrospectively from hospital records, including demographic details, indications for CM, fibroid characteristics, intraoperative parameters, and postoperative outcomes. Descriptive statistical analysis was used to summarize the findings. Results The mean maternal age was 34.5 years (range: 27-40 years), and the gestational age at delivery varied from 35 weeks and 4 days to 38 weeks and 6 days. The most common indication for cesarean section was fibroid-related concerns, including lower uterine segment (LUS) fibroids, multiple fibroids, and fibroids in patients with prior cesarean deliveries. Fibroid numbers ranged from one to fifteen per patient, with intramural fibroids (FIGO 4) being the most frequent type. The mean intraoperative blood loss was 620 mL (range: 450-800 mL), with no case of postpartum hemorrhage. The mean operative time was 74 minutes, and two patients required blood transfusions. No patients required intensive care, and the average hospital stay was 3.6 days. Neonatal outcomes were favorable, with a mean birth weight of 2.92 kg and reassuring APGAR scores. Three neonates required NICU admission for transient tachypnea, small for gestational age, and meconium aspiration syndrome. Conclusion CM, when performed in appropriately selected cases, is a feasible and safe procedure. It eliminates the need for a second surgery, reduces future fibroid-related complications, and does not significantly increase maternal morbidity. These findings support the growing consideration of CM as a viable surgical option in select cases. Further prospective studies are needed to establish standardized protocols for patient selection and surgical technique.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.